Clinical trials
Safety Issues clinical trials
Below are recruiting safety issues clinical trials, each written for real people, not researchers. We’re tracking 20 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06123611Enrolling by invitation
Gun safety study for pediatric trauma patients and their families
This study looks at how to improve gun safety practices among families of children hospitalized for injuries. It involves parents or guardians and injured youth ages 11-17 at participating trauma centers.
Baltimore, MarylandAges 11 years+ - NCT06302452Enrolling by invitation
Adult trauma centers and gun safety study
This study looks at how adult trauma centers help patients stay safe from guns. You may be asked about your access to firearms and get tools to reduce risk.
Baltimore, MarylandAges 18 years+ - NCT06076512Recruiting
Pain clinic safety trial for adults with chronic pain
This trial is testing whether a pain clinic can improve public health safety for adults who have chronic pain and also face social or emotional challenges. It aims to see if this kind of care helps people feel better and avoids opioid-related harms.
Surrey, British ColumbiaAges 20–99 - NCT07674862Enrolling by invitationPhase 1
Safety study of ETD-001 gel in healthy Chinese adults
This trial tests a new gel called ETD-001 on healthy volunteers to see if it's safe and how the body processes it. If you are a healthy Chinese adult, you might be able to join.
Hangzhou, ZhejiangAges 16–60 - NCT07058779RecruitingPhase 1
Safety study of SSS55 in healthy volunteers
This trial is testing a new medicine called SSS55 in healthy adults to see if it is safe and how the body processes it. Participants will receive meningococcal and pneumococcal vaccines before the study.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT06383377Recruiting
New bone graft for tooth extraction and implant
This study tests a new bone graft material called Wishbone HA used after tooth extraction to prepare for a dental implant. It is for people who need a tooth pulled and have healthy gums and good bone support.
Louvain-la-Neuve, Brabant WallonAges 18–80 - NCT05164263RecruitingPhase 4
Testing empagliflozin for adults with type 2 diabetes on tablets
This study looks at how well and how safely empagliflozin works in real-world care for adults with type 2 diabetes who are not controlled on current pill treatment. Some participants take it with metformin, and the study helps confirm what to expect in everyday patients.
Kabul, AfghanistanAges 18–65 - NCT04861506Recruiting
Clot-removal treatment for blocked blood flow in the leg
This trial tests how safe and effective a clot-removal procedure done through the blood vessels is for people with acute or subacute blocked blood flow in the lower leg. It may help by improving circulation while carefully tracking risks and results.
Hangzhou, ZhejiangAges 18 years+ - NCT05583006Recruiting
Switch from entecavir to tenofovir for chronic hepatitis B
This trial studies switching people with chronic hepatitis B from entecavir (ETV) to tenofovir alafenamide (TAF). It may help if you feel your current entecavir treatment isn’t working well enough or is inconvenient.
Taichung, TaiwanAges 20 years+ - NCT05517291Recruiting
Compare two stent types for blocked thigh artery disease
This trial compares a special drug-coated balloon/stent strategy versus a standard stent approach for people with blocked thigh artery segments. It aims to improve how long the artery stays open and reduces repeat procedures.
BeijingAges 18–85 - NCT06485141Recruiting
Safe Storage Counseling for Caregivers of Hospitalized Children
This study tests if a counseling session about safe firearm storage can help caregivers of hospitalized children. You will receive guidance and follow-up to see if it makes a difference in safety habits.
Aurora, ColoradoAges 18 years+ - NCT06509490Recruiting
CAR-T cell therapy for advanced NKG2DL-positive solid tumors
This trial tests a new type of immune cell therapy (NKG2D CAR-T cells) for people with advanced solid tumors that have not responded to standard treatments. It aims to see if these specially engineered cells can shrink tumors or slow their growth.
Beijing, Beijing MunicipalityAges 18–70 - NCT06468943Enrolling by invitationPhase 2
New drug combo for non-GCB diffuse large B-cell lymphoma
This trial tests a combination of three targeted drugs (polatuzumab vedotin, zanubrutinib, and R-CHP) for people newly diagnosed with a specific subtype of DLBCL called non-GCB. The goal is to see if this powerful mix can work better than standard treatment.
Suzhou, NanjingAges 18 years+ - NCT04270786Recruiting
De-escalating antibiotics early for neutropenic fever
This study looks at whether doctors can safely use fewer/less intense antibiotics after fever improves in adults with low white blood cell counts after a stem cell transplant. It may help reduce unnecessary antibiotic exposure while still treating serious infections.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT05916898Recruiting
Shockwave treatment after difficult stent expansion
This registry studies how well shockwave therapy works when a previously placed heart stent does not expand well, especially when the artery is quite calcified. Your care team would use it after other tools to prepare the blockage have not worked.
Legnica, Lower Silesian VoivodeshipAges 18–99 - NCT06284057Recruiting
Culotte stent technique study for Y-shaped heart blockages
This trial studies two different ways of placing stents in Y-shaped blockages in the heart's arteries. It aims to find which technique works best for people who need two stents in that area.
Legnica, Lower Silesian VoivodeshipAges 18 years+ - NCT06288165Recruiting
Sinus reducer trial for persistent chest pain
This study tests a device called the sinus reducer for people with long-lasting chest pain that hasn't improved with medication or other procedures. It may help if you have limited options for treatment.
Lubin, Lower Silesian VoivodeshipAges 18 years+ - NCT06451146Recruiting
Orbital atherectomy for calcified heart blockages
This trial studies a procedure called orbital atherectomy to treat hardened calcium deposits in heart arteries. It aims to help people with moderately to severely calcified blockages.
Legnica, Lower Silesian VoivodeshipAges 18 years+ - NCT06498167Recruiting
Rinvoq safety study
This study is checking the safety of the medicine Rinvoq (upadacitinib) in people who have been prescribed it. It involves answering a few questions over the phone to help doctors understand how the medicine is working for you.
PortoAges 18 years+ - NCT06742437Recruiting
Study of a new sperm preparation method
This study tests a new method for preparing sperm to help with fertility treatments. It is for men who can provide a semen sample and have no active infections or history of certain viruses.
Barcelona, BarcelonaAges 18–60
Hear when a new Safety Issues trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for safety issues?
- Yes. Clin2 currently lists 20 recruiting safety issues studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a safety issues trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a safety issues trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.